Babak Tofighi, MD, MSc
NYU Langone Health - Assistant Professor, Department of Population Health
NYU Langone Health - Assistant Professor, Department of Medicine
NYU Langone Health - Assistant Professor, Department of Medicine
Email: Babak.Tofighi@nyulangone.org
Research Interests
mHealth, Illicit drug & alcohol use disorders BIO
Babak Tofighi is an Assistant Professor in the Departments of Population Health and Medicine, primary care provider at Bellevue Hospital, Research Scientist at the Nathan Kline Institute Department of Social Solutions and Services Research, and clinical advisor to Oarhealth.com. His research primarily centers on integrating health information technologies to enhance access to primary care, substance use treatment, and social services among vulnerable populations with substance use disorders. Projects
Principal Investigator, SOAR: Smartphones for Opioid Addiction Recovery. Active
Principal Investigator, Development of a Text Messaging Tool to Support Buprenorphine Treatment in Primary Care. Completed
Publications
Recent
Tofighi B, Martino D, Lekas HM, Williams SZ, Blau C, Lewis CF (2023).
Scaling opioid overdose prevention and naloxone dispensation among rural and small metro area pharmacists: Findings from a qualitative study
Journal of Substance Use, 28 (4), 568-573. doi: 10.1080/14659891.2022.2070877.
Scaling opioid overdose prevention and naloxone dispensation among rural and small metro area pharmacists: Findings from a qualitative study
Journal of Substance Use, 28 (4), 568-573. doi: 10.1080/14659891.2022.2070877.
Tofighi B, Badiei B, Badolato R, Lewis CF, Nunes E, Thomas A, Lee JD (2023).
Integrating text messaging in a low threshold telebuprenorphine program for New York City residents with opioid use disorder during COVID-19: A pilot randomized controlled trial
Journal of Addiction Medicine [Epub 2023 Mar 31]. doi: 10.1097/ADM.0000000000001161.
Integrating text messaging in a low threshold telebuprenorphine program for New York City residents with opioid use disorder during COVID-19: A pilot randomized controlled trial
Journal of Addiction Medicine [Epub 2023 Mar 31]. doi: 10.1097/ADM.0000000000001161.
Tofighi B, Marini C, Lee JD, Garland EL (2023).
Patient perceptions of integrating meditation-based interventions in office-based opioid treatment with buprenorphine: A mixed-methods survey
Journal of Addiction Medicine [Epub 2023 Mar 28]. doi: 10.1097/ADM.0000000000001160.
Patient perceptions of integrating meditation-based interventions in office-based opioid treatment with buprenorphine: A mixed-methods survey
Journal of Addiction Medicine [Epub 2023 Mar 28]. doi: 10.1097/ADM.0000000000001160.
Marini C, Northover NS, Gold ND, Rogers UK, O'Donnell KC, Tofighi B, Ross S, Bogenschutz MP (2023).
A systematic approach to standardizing drinking outcomes from timeline followback data
Substance Abuse: Research and Treatment, 17, 11782218231157558. doi: 10.1177/11782218231157558. PMCID: PMC10009017.
A systematic approach to standardizing drinking outcomes from timeline followback data
Substance Abuse: Research and Treatment, 17, 11782218231157558. doi: 10.1177/11782218231157558. PMCID: PMC10009017.
Tofighi B, Lopez R, Araujo G, Lee JD, Samuels EA, Wightman RS, Butner J (2023).
Provider and administrator attitudes and experiences with implementing telebuprenorphine during the COVID-19 pandemic: A mixed-methods survey
Journal of Substance Use [Epub 2023 Jan 13]. doi: 10.1080/14659891.2023.2166609.
Provider and administrator attitudes and experiences with implementing telebuprenorphine during the COVID-19 pandemic: A mixed-methods survey
Journal of Substance Use [Epub 2023 Jan 13]. doi: 10.1080/14659891.2023.2166609.